Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 224 participants.
Also called NCT01474200
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 224 participants
- Sponsor
- Nuwellis, Inc.
- Registry
-
NCT01474200
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01474200. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-07 (actual). Results posted on 2015-10-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
- Acronym
- AVOID-HF
- Condition
- Heart Failure
- Condition
- Cardiac Failure
- Condition
- Acute Decompensated Heart Failure (ADHF)
- Intervention (Device)
- Isolated veno-venous ultrafiltration (AQ)
- Intervention (Drug)
- IV Loop Diuretics (LD)
- Lead sponsor
- Nuwellis, Inc.
Record details
- Record id
cardio:ct-nct01474200- Content hash
fe1d8bb0a30fccaa359f606437347822f6c1a886490b8314001dd6c629900c03